Tag
Biotechnology
10 articles
India’s biotechnology sector is experiencing a surge in activity, driven by government initiatives and private investment. A focus on leveraging the nation’s unique genetic diversity for global gene research, alongside increased industry participation and streamlined regulatory pathways like the SHANTI Act, positions India as a potential leader in the field. Simultaneously, companies like Biocon and Advanced Enzyme Technologies are preparing to update investors on their financial performance, while Genomic Valley Biotech is undergoing a significant ownership shift with a mandatory open offer triggered by a substantial stake acquisition. Finally, Balrampur Chini Mills’ receipt of a substantial BioE3 grant underscores the government’s commitment to bolstering the bioeconomy through sustainable materials innovation.
Glenmark's IGI Submits IND for ISB 2301 Cancer Drug
Ichnos Glenmark Innovation submitted an IND application to U.S. FDA for ISB 2301, a first-in-class multispecific immune cell activator targeting solid tumors.
The pentaspecific molecule targets three
Suven Life Sciences Presents Alzheimer's Drug Data at CTAD-2026
Suven Life Sciences will present Phase-3 baseline data for Masupirdine and Phase-1 safety data for Tenaclidine at the CTAD-2026 conference in Boston.
Masupirdine Phase-3 study targeting agitation in A
Biocon Gets U.S. FDA Approval for Pebrilzo Biosimilar
Biocon Limited received U.S. FDA approval for Pebrilzo™ (pertuzumab-qcay), a biosimilar to Perjeta®, for HER2-positive breast cancer treatment.
The approval strengthens Biocon's oncology portfolio to
Transgene Biotek Announces Book Closure for 36th AGM
Transgene Biotek's register of members will close from December 24 to 30, 2026, for its 36th Annual General Meeting.
The AGM is scheduled for December 30, 2026, at 11:00 AM IST via video conferencing.
Novelix Pharmaceuticals Signs axabio Astaxanthin Supply Agreement
Novelix Pharmaceuticals entered an international supply agreement with Belgian biotech firm axabio NV for natural astaxanthin.
The agreement, dated 12th November 2026, is expected to generate meaningf
BRIC Foundation Day Highlights India's Biotech Growth
India's bioeconomy grew from $10 billion to over $195 billion, with biotechnology startups increasing from 50-60 to over 11,000.
BRIC signed Letter of Intent with UK's Centre for Process Innovation to
India's Bioeconomy Hits $195 Billion, BRIC Expands
India's bioeconomy grew from $10 billion to over $195 billion, with biotech startups surging from 50 to over 11,000.
BRIC signed a Letter of Intent with UK's Centre for Process Innovation to strengthe
Genomic Valley Biotech 26% Open Offer at ₹30
Pankaj Grover and Abhisek Gupta launch mandatory open offer for 26% of Genomic Valley Biotech shares at ₹30 per share.
Offer triggered by acquisition of 46.06% stake from promoter Yogesh Agrawal for ₹
Genomic Valley Biotech Promoter Sells 46.06% Stake
Promoter Yogesh Agrawal executed Share Purchase Agreement to sell entire 46.06% stake to Pankaj Grover and Abhisek Gupta.
Transaction triggers mandatory open offer obligation under SEBI SAST Regulatio
BCML Receives ₹75 Crore BioE3 Grant for PLA R&D
Balrampur Chini Mills awarded ₹75 crore grant by BIRAC for PLA Co-Polymer R&D Facility under BioE3 initiative.
The 100 TPA pilot facility at Kumbhi, UP will develop advanced biopolymers and indigenous